Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

IMPORTANCE: B-cell–depleting monoclonal antibodies are widely used for treatment of multiple sclerosis but are associated with an impaired response to vaccines. OBJECTIVE: To identify factors associated with a favorable vaccine response to tozinameran. DESIGN, SETTING, AND PARTICIPANTS: This prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolf, Andreas, Wiberg, Anna, Müller, Malin, Nazir, Faisal Hayat, Pavlovic, Ivan, Laurén, Ida, Mangsbo, Sara, Burman, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096596/
https://www.ncbi.nlm.nih.gov/pubmed/35544139
http://dx.doi.org/10.1001/jamanetworkopen.2022.11497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096596/
https://www.ncbi.nlm.nih.gov/pubmed/35544139
http://dx.doi.org/10.1001/jamanetworkopen.2022.11497

Ejemplares similares